GTBP 经营现金流历史(2016–2025)
GT Biopharma, Inc. (GTBP) 年度经营现金流历史(来自 SEC 财报)—— 每个财年经营活动产生的现金净额。
-$12.9MFY2025 · FY2016 以来:-$1.9M → -$12.9M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | -$12.9M | -0.1% |
| FY2024 | -$12.9M | -45.8% |
| FY2023 | -$8.9M | +41.8% |
| FY2022 | -$15.2M | +2.5% |
| FY2021 | -$15.6M | -114.9% |
| FY2020 | -$7.3M | -98.5% |
| FY2019 | -$3.7M | +65.7% |
| FY2018 | -$10.7M | -96.6% |
| FY2017 | -$5.4M | -181.3% |
| FY2016 | -$1.9M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议